SEC Form 4 · accession 0001209191-19-006009
PROTEOSTASIS THERAPEUTICS, INC. · PTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Po Shun Lee
Officer — See Remarks
Period of report
Jan 28, 2019
Accepted (ET)
Jan 30, 2019 · 4:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001445283
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 28, 2019 | S | 1,600 | $3.00 | D | 3,024 | D | |
| Common StockF1 | Jan 29, 2019 | S | 712 | $3.00 | D | 2,312 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2Includes 712 shares acquired on June 30, 2018 and 2,312 shares acquired on December 31, 2018, in each case pursuant to PTI's 2016 Employee Stock Purchase Plan.
Remarks
Title: Executive Vice President and Chief Medical Officer